Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Oncolytics Biotech buy Lake Street Capital

Start price
€1.61
13.08.25 / 50%
Target price
€5.99
13.08.26
Performance (%)
-
End price
-
14.08.26
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Oncolytics Biotech - - -
iShares Core DAX® 0.437% 5.640% 7.806%
iShares Nasdaq 100 1.057% 0.282% 27.239%
iShares Nikkei 225® 1.769% 0.406% 49.266%
iShares S&P 500 0.368% 1.920% 22.336%

Comments by Lake_Street_Capital for this prediction

In the thread Oncolytics Biotech diskutieren
Prediction Buy
Perf. (%) -
Target price 5.995
Change
Ends at 13.08.26

Oncolytics Biotech Inc. (NASDAQ: ONCY) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $7.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat

In the thread Trading Oncolytics Biotech
Prediction Buy
Perf. (%) -
Target price 5.995
Change
Ends at 13.08.26

Die von Lake_Street_Capital gewählte maximale Laufzeit wurde überschritten